William M. Feinberg lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors

被引:42
作者
Gorelick, PB [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Neurol & Rehabil, Chicago, IL 60612 USA
关键词
cognitive disorders; risk factors; vascular disorders;
D O I
10.1161/01.STR.0000158916.59742.7c
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - Vascular risk factors are common in the elderly, and some such as hypertension may be important predictors of cognitive impairment. Summary of Review - In this article, the role that vascular risk factors may play in the prevention of vascular and nonvascular forms of cognitive impairment is reviewed. Conclusions - Because vascular risk factors may have negative effects on brain structure and cognitive function, and because vascular risk factors may be present in midlife or possibly earlier, we may need to develop long-term intervention strategies to control or prevent vascular risk factors in an effort to preserve cognitive vitality as we age.
引用
收藏
页码:875 / 879
页数:5
相关论文
共 43 条
[1]   Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial [J].
Aisen, PS ;
Schafer, KA ;
Grundman, M ;
Pfeiffer, E ;
Sano, M ;
Davis, KL ;
Farlow, MR ;
Jin, S ;
Thomas, RG ;
Thal, LJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2819-2826
[2]   A randomized controlled trial of prednisone in Alzheimer's disease [J].
Aisen, PS ;
Davis, KL ;
Berg, JD ;
Schafer, K ;
Campbell, K ;
Thomas, RG ;
Weiner, MF ;
Farlow, MR ;
Sano, M ;
Grundman, M ;
Thal, LJ .
NEUROLOGY, 2000, 54 (03) :588-593
[3]   Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[4]   Unique lipoprotein phenotype and genotype associated with exceptional longevity [J].
Barzilai, N ;
Atzmon, G ;
Schechter, C ;
Schaefer, EJ ;
Cupples, AL ;
Lipton, R ;
Cheng, S ;
Shuldiner, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15) :2030-2040
[5]   Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins [J].
Casserly, I ;
Topol, E .
LANCET, 2004, 363 (9415) :1139-1146
[6]   CT AND MRI FINDINGS AMONG - AFRICAN-AMERICANS WITH ALZHEIMERS-DISEASE, VASCULAR DEMENTIA, AND STROKE WITHOUT DEMENTIA [J].
CHARLETTA, D ;
GORELICK, PB ;
DOLLEAR, TJ ;
FREELS, S ;
HARRIS, Y .
NEUROLOGY, 1995, 45 (08) :1456-1461
[7]   Framingham stroke risk profile and lowered cognitive performance [J].
Elias, MF ;
Sullivan, LM ;
D'Agostino, RB ;
Elias, PK ;
Beiser, A ;
Au, R ;
Seshadri, S ;
DeCarli, C ;
Wolf, PA .
STROKE, 2004, 35 (02) :404-409
[8]   Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies [J].
Etminan, M ;
Gill, S ;
Samii, A .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7407) :128-+
[9]  
EVANS GJ, 1988, EPIDEMIOLOGY AGING I, P36
[10]   Achieving and maintaining cognitive vitality with aging [J].
Fillit, HM ;
Butler, RN ;
O'Connell, AW ;
Albert, MS ;
Birren, JE ;
Cotman, CW ;
Greenough, WT ;
Gold, PE ;
Kramer, AF ;
Kuller, LH ;
Perls, TT ;
Sahagan, BG ;
Tully, T .
MAYO CLINIC PROCEEDINGS, 2002, 77 (07) :681-696